FDA Under Pressure From Right After Abortion Pill Approval
7 Articles
7 Articles
FDA under pressure from right after abortion pill approval
The anti-abortion movement’s patience with the Food and Drug Administration (FDA) is wearing thin following the agency’s recent approval of a second generic version of mifepristone, one of two drugs taken for a medication abortion. President Trump repeatedly pledged during the campaign last year that he would leave abortion policy to the states, but…
Pro-life coalition urges HHS, FDA to reverse approval of new abortion pill
A coalition of pro-life advocates, including Kelsey Reinhardt, president and CEO of CatholicVote, on Friday called on Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration Commissioner Marty Makary to immediately reverse the FDA’s recent approval of a new generic version of the abortion drug mifepristone.
Pro-Life Advocates Object as Trump FDA Approves New Generic Pill for Abortion, Again
Signage is seen outside of the Food and Drug Administration headquarters in White Oak, Md., Aug. 29, 2020. FDA has approved Evita Solution’s new generic version of the drug commonly used for early abortion, mifepristone, the regulator said Sept. 30, 2025. The first generic form of the pill was approved in 2019 under the first Trump administration. (Photo: OSV News/Andrew Kelly, Reuters) WASHINGTON (OSV News) – The Food and Drug Administration re…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium